Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mayocp.2013.10.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Superficial fibromatosis: MRI radiomics and T2 mapping correlate with treatment response.
Magn Reson Imaging
September 2021
Department of Radiology, Sylvester Comprehensive Cancer Center, the University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, FL 33136, USA. Electronic address:
Background: Superficial fibromatosis exhibits variable MR signal intensity due to collagenous and fibroproliferative components. Quantifying this signal heterogeneity using image texture analysis and T2-mapping could have prognostic and therapeutic implications.
Methods: This IRB-approved retrospective study included 13 patients with superficial fibromatosis, managed by observation, electron beam radiotherapy (EBT), or pentoxifylline/vitamin E.
MRI appearance of the different meniscal ramp lesion types, with clinical and arthroscopic correlation.
Skeletal Radiol
May 2020
University of Miami Sports Medicine Institute, 5555 Ponce de Leon Blvd, Coral Gables, FL, 33146, USA.
Background: Meniscal ramp lesions have been defined as longitudinal vertical peripheral tears of the medial meniscus involving the posterior meniscocapsular ligament, meniscotibial ligament, and/or the red-red zone of the posterior horn. They are heavily associated with anterior cruciate ligament injuries, and because of their potentially important biomechanical role in knee stabilization, injuries to this region may require surgical repair. However, due to their location and lack of general knowledge regarding their different types and associated appearances on magnetic resonance imaging, ramp lesions are routinely underreported.
View Article and Find Full Text PDFVehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
J Am Acad Dermatol
August 2007
Wake Forest University School of Medicine, Department of Dermatology, Medical Center Blvd, Winston-Salem, NC 27157, USA.
Background: A shorter dosing regimen of imiquimod for the treatment of actinic keratosis may be effective, with long-term clinical benefits.
Objective: Imiquimod in one or two shorter courses of treatment was evaluated.
Methods: Patients with actinic keratosis lesions on the head applied imiquimod or vehicle cream 3x/wk for 4 weeks (course 1).
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
J Am Acad Dermatol
October 2004
Klinikum der Universität Regensburg, Klinik und Poliklinik für Dermatologie, Regensburg, Germany.
Background: Increasing evidence suggests imiquimod may be a safe therapeutic option for the treatment of actinic keratosis (AK). The diagnosis and assessment of most AK lesions is made clinically, without histologic confirmation.
Objective: A phase III, randomized, double-blind, parallel group, vehicle-controlled study evaluated the efficacy of imiquimod 5% cream compared with vehicle in the treatment of AK lesions on the face and balding scalp including pretreatment and posttreatment biopsy specimens.
Williams syndrome associated with Crohn disease, multiple infections, and chronic granulomatous disease.
Fetal Pediatr Pathol
January 2004
Department of Pathology and Laboratory Medicine, University of South Florida College of Medicine, Tampa 33606, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!